| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.87B | +4.3% |
| Gross profit | ¥1.29B | — |
| Operating income | ¥0.48B | — |
| Net income | ¥0.40B | -13.6% |
| Gross margin | 69.1% | Net margin 21.6% |
| Revenue Q/Q | +38.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.58B | 30.9% |
| R&D | ¥0.03B | 1.4% |
| SG&A | ¥0.79B | 42.2% |
| Tax & other | ¥0.08B | 4.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
*ST香雪 ・ 天舟文化 ・ 睿智医药 ・ 世纪瑞尔 ・ 昌红科技 ・ *ST动力 ・ 科泰电源 ・ 瑞凌股份 ・ 安居宝 ・ 新锦动力 ・ 振东制药 ・ 新研股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies